Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: Patient-reported outcomes across two randomised clinical trials
Andrew X. Zhu, Ryan D. Nipp, Richard S. Finn, Peter R. Galle, Josep M. Llovet, Jean Frederic Blanc, Takuji Okusaka, Ian Chau, David Cella, Allicia Girvan, Jonathon Gable, Lee Bowman, Chunxiao Wang, Yanzhi Hsu, Paolo B. Abada, Masatoshi Kudo
Research output: Contribution to journal › Article › peer-review
17Scopus
citations
Fingerprint
Dive into the research topics of 'Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: Patient-reported outcomes across two randomised clinical trials'. Together they form a unique fingerprint.